Beam Therapeutics Inc.

$BEAM

Public valuation for Beam Therapeutics Inc. (BEAM). Fair value, signal, and key metrics — no sign-in required.

Current Price $27.23

42% Overvalued

Fair Value Estimate $16

🚧 Turnaround

Negative earnings but showing signs of recovery

Target: $49.38

81% higher than current

Key Metrics

Market Cap $2.8B

Operating Margin -25869.0%

Revenue Growth 218.1%

Last updated: November 01, 2026

Join the waitlist for valuation updates on $BEAM and the rest of your watchlist.

Stay on this page to join — no sign-in required.